State Street’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,673,621
Closed -$33M 4336
2024
Q4
$33M Sell
2,673,621
-328,882
-11% -$3.77M ﹤0.01% 1935
2024
Q3
$34.2M Sell
3,002,503
-330,097
-10% -$3.31M ﹤0.01% 1895
2024
Q2
$23.8M Sell
3,332,600
-2,515,567
-43% -$19.2M ﹤0.01% 2084
2024
Q1
$39.2M Buy
5,848,167
+1,063,928
+22% +$7.32M ﹤0.01% 1851
2023
Q4
$31.1M Buy
4,784,239
+1,049,172
+28% +$6.76M ﹤0.01% 1958
2023
Q3
$35.3M Sell
3,735,067
-148,752
-4% -$1.79M ﹤0.01% 1823
2023
Q2
$54.3M Buy
3,883,819
+142,442
+4% +$2.43M ﹤0.01% 1620
2023
Q1
$70.2M Sell
3,741,377
-1,382,429
-27% -$22.7M ﹤0.01% 1425
2022
Q4
$70.6M Buy
5,123,806
+1,241,764
+32% +$19M ﹤0.01% 1406
2022
Q3
$74.2M Sell
3,882,042
-397,267
-9% -$7.24M ﹤0.01% 1315
2022
Q2
$65.3M Sell
4,279,309
-123,773
-3% -$1.83M ﹤0.01% 1450
2022
Q1
$89.7M Buy
4,403,082
+677,944
+18% +$13.8M ﹤0.01% 1371
2021
Q4
$109M Buy
3,725,138
+570,796
+18% +$16.3M 0.01% 1242
2021
Q3
$68M Buy
3,154,342
+640,281
+25% +$15.5M ﹤0.01% 1579
2021
Q2
$64.5M Buy
2,514,061
+1,542,402
+159% +$32.9M ﹤0.01% 1661
2021
Q1
$17.7M Buy
971,659
+23,047
+2% +$383K ﹤0.01% 2435
2020
Q4
$10.9M Sell
948,612
-43,668
-4% -$399K ﹤0.01% 2582
2020
Q3
$7.56M Sell
992,280
-65,922
-6% -$499K ﹤0.01% 2591
2020
Q2
$6.95M Buy
1,058,202
+19,529
+2% +$109K ﹤0.01% 2602
2020
Q1
$5.31M Sell
1,038,673
-21,871
-2% -$132K ﹤0.01% 2596
2019
Q4
$8.13M Buy
1,060,544
+32,716
+3% +$191K ﹤0.01% 2626
2019
Q3
$5.45M Buy
1,027,828
+87,955
+9% +$546K ﹤0.01% 2744
2019
Q2
$5.26M Buy
939,873
+75,776
+9% +$312K ﹤0.01% 2793
2019
Q1
$3.67M Buy
864,097
+50,674
+6% +$207K ﹤0.01% 2899
2018
Q4
$3.33M Buy
813,423
+18,041
+2% +$94.1K ﹤0.01% 2905
2018
Q3
$5.46M Buy
795,382
+96,393
+14% +$571K ﹤0.01% 2825
2018
Q2
$2.74M Buy
698,989
+663,969
+1,896% +$2.3M ﹤0.01% 3130
2018
Q1
$101K Buy
35,020
+11,974
+52% +$37K ﹤0.01% 3614
2017
Q4
$89K Buy
23,046
+8,529
+59% +$36.5K ﹤0.01% 3610
2017
Q3
$45K Hold
14,517
﹤0.01% 3671
2017
Q2
$63K Hold
14,517
﹤0.01% 3576
2017
Q1
$67K Hold
14,517
﹤0.01% 3559
2016
Q4
$31K Hold
14,517
﹤0.01% 3585
2016
Q3
$43K Hold
14,517
﹤0.01% 3495
2016
Q2
$37K Sell
14,517
-349,297
-96% -$974K ﹤0.01% 3614
2016
Q1
$1.07M Buy
363,814
+15,233
+4% +$81.5K ﹤0.01% 3199
2015
Q4
$2.85M Buy
348,581
+8,432
+2% +$68.1K ﹤0.01% 2845
2015
Q3
$2.43M Sell
340,149
-6,056
-2% -$50.5K ﹤0.01% 2916
2015
Q2
$3.18M Buy
346,205
+24,936
+8% +$240K ﹤0.01% 2869
2015
Q1
$3.04M Buy
321,269
+2,000
+0.6% +$19.3K ﹤0.01% 2838
2014
Q4
$3.1M Buy
319,269
+8,765
+3% +$88.3K ﹤0.01% 2825
2014
Q3
$2.95M Buy
310,504
+2,988
+1% +$33.5K ﹤0.01% 2813
2014
Q2
$4.05M Sell
307,516
-175
-0.1% -$2.21K ﹤0.01% 2711
2014
Q1
$4.09M Buy
307,691
+53,379
+21% +$703K ﹤0.01% 2688
2013
Q4
$2.47M Buy
254,312
+30,719
+14% +$289K ﹤0.01% 2965
2013
Q3
$2.21M Buy
223,593
+30,233
+16% +$300K ﹤0.01% 2985
2013
Q2
$1.74M Buy
+193,360
New +$2.03M ﹤0.01% 3044

Other funds holding CDMO

State Street's CDMO Position: Q1 2025 in Review

State Street sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 2,673,621 shares — an estimated $33M sold.

State Street first reported a position in CDMO in Q2 2013 and held it in 47 quarters. The position peaked at $109M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • State Street reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • State Street sold 2,673,621 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $33M.
  • State Street first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 47 quarters.
  • State Street's Avid Bioservices, Inc. Common Stock position peaked at $109M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on State Street's 13F filing for Q1 2025, filed 15 May 2025.